• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hum Vaccin Immunother . Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?

tetano

Editor, Senior Moderator
Hum Vaccin Immunother


. 2020 Nov 12;1-2.
doi: 10.1080/21645515.2020.1829413. Online ahead of print.
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?


Laura Sticchi[SUP] 1 2 [/SUP], Lucia Taramasso[SUP] 1 [/SUP], Antonio Di Biagio[SUP] 1 3 [/SUP], Dario Olobardi[SUP] 2 [/SUP], Giancarlo Icardi[SUP] 1 2 [/SUP], Matteo Bassetti[SUP] 1 2 [/SUP]



Affiliations

Abstract

We have checked the vaccination history of 389 elderly patients (62.9% males, mean age of 78.5 + 8.4 years) hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. Information regarding pneumococcal vaccination was available for 354 patients (91.0%): the overall vaccination coverage rate (VCR) was 19.8% (70/354), 11.3% received only 13-valent pneumococcal conjugate vaccine (PCV13), 3.4% were immunized with 23-valent pneumococcal polysaccharide vaccine (PPSV23), 5.1% received both vaccines. VCR among the elderly population in Liguria Region was 26.2% (118,581/453,082), among them 13.7% received PCV13, 12.4% were immunized with at least one dose of PPSV23. Regarding the 2019-2020 influenza season vaccination data were available for 46 patients: 59% of them were immunized. VCR in the elderly population was 51.7% (234,153/453,082).

Keywords: Streptococcus pneumoniae; Hesitancy; Italy; influenza; vaccine.
 
Back
Top Bottom